Skip to main content

Smith Mary L.'s Form 4 filing

PTC Therapeutics, Inc. (PTCT) · filed Jul 13, 2026

Accession no.
0001866044-26-000005
Filed
Jul 13, 2026, 5:20 PM ET
Trade date
Jul 9, 2026
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.43M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Smith Mary L.CIK 0001866044Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 9, 2026Common StockMOption exerciseAcquired+10,000$42.95+$429,50031,813Direct
Jul 9, 2026Common StockSSaleDisposed−10,000$90.00−$900,00021,813Direct
Jul 9, 2026Common StockMOption exerciseAcquired+5,834$42.95+$250,570.327,647Direct
Jul 9, 2026Common StockSSaleDisposed−5,834$90.00−$525,06021,813Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 9, 2026Common StockMOption exerciseDisposed−10,000$0.00$00Direct
Jul 9, 2026Common StockMOption exerciseDisposed−5,834$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)